Menactra®

Menactra^®

Menactra^® is indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135.
It is approved for use in individuals 9 months through 55 years of age.

View all

SEROGROUP A is responsible for majority of MENINGOCOCCAL MENINGITIS outbreaks in India1

Read article

Vaccinate against meningococcal meningitis

Read article

The startling statistics of IMD severity

Read article

IMD Roadshow: Defeating meningitis by 2023: Dr. Jaydeep Choudhury

Read article

IMD progression & consequences are inversely proportional to age

Read article

10 years and still going strong with Menactra

Read article

The relevant and trusted MCV in India to fight against meningococcal meningitis

Read article

Menactra: Preventing meningococcal meningitis in India

Read article

View all

Disclaimer: Patient images depicted here are fictitious and meant for illustrative purpose only. Any resemblance to any person, living or dead is purely coincidental.